Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism
Phase 3
- Conditions
- Hypogonadism
- Interventions
- Drug: Testogel 1%Drug: Placebo
- First Posted Date
- 2013-02-08
- Last Posted Date
- 2013-02-08
- Lead Sponsor
- Laboratoires Besins International
- Target Recruit Count
- 240
- Registration Number
- NCT01786473
- Locations
- 🇨🇳
Peking University First Hospital, Peking, China
© Copyright 2025. All Rights Reserved by MedPath